BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 29176494)

  • 21. [Not Available].
    Lenglinger J; Hädrich M
    Ther Umsch; 2016 Nov; 73(9):500-504. PubMed ID: 27805488
    [No Abstract]   [Full Text] [Related]  

  • 22. Evaluation of stool collections to measure efficacy of PERT in subjects with exocrine pancreatic insufficiency.
    Caras S; Boyd D; Zipfel L; Sander-Struckmeier S
    J Pediatr Gastroenterol Nutr; 2011 Dec; 53(6):634-40. PubMed ID: 21681115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preliminary report of the (13)C-mixed triglyceride breath test to assess timing of pancreatic enzyme replacement therapy in children with cystic fibrosis.
    van der Haak N; Boase J; Davidson G; Butler R; Miller M; Kaambwa B; Kritas S
    J Cyst Fibros; 2016 Sep; 15(5):669-74. PubMed ID: 27102891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical evaluation of an evidence-based method based on food characteristics to adjust pancreatic enzyme supplements dose in cystic fibrosis.
    Calvo-Lerma J; Boon M; Colombo C; de Koning B; Asseiceira I; Garriga M; Roca M; Claes I; Bulfamante A; Walet S; Pereira L; Ruperto M; Masip E; Asensio-Grau A; Giana A; Affourtit P; Heredia A; Vicente S; Andrés A; de Boeck K; Hulst J; Ribes-Koninckx C
    J Cyst Fibros; 2021 Sep; 20(5):e33-e39. PubMed ID: 33279468
    [TBL] [Abstract][Full Text] [Related]  

  • 25. International phase III trial of liprotamase efficacy and safety in pancreatic-insufficient cystic fibrosis patients.
    Borowitz D; Stevens C; Brettman LR; Campion M; Chatfield B; Cipolli M;
    J Cyst Fibros; 2011 Dec; 10(6):443-52. PubMed ID: 21831726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nutritional status, nutrient intake and use of enzyme supplements in paediatric patients with Cystic Fibrosis; a European multicentre study with reference to current guidelines.
    Calvo-Lerma J; Hulst JM; Asseiceira I; Claes I; Garriga M; Colombo C; Fornés V; Woodcock S; Martins T; Boon M; Ruperto M; Walet S; Speziali C; Witters P; Masip E; Barreto C; de Boeck K; Ribes-Koninckx C;
    J Cyst Fibros; 2017 Jul; 16(4):510-518. PubMed ID: 28320633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype.
    De Boeck K; Weren M; Proesmans M; Kerem E
    Pediatrics; 2005 Apr; 115(4):e463-9. PubMed ID: 15772171
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pancreatic enzyme replacement therapy dosing and nutritional outcomes in children with cystic fibrosis.
    Haupt ME; Kwasny MJ; Schechter MS; McColley SA
    J Pediatr; 2014 May; 164(5):1110-1115.e1. PubMed ID: 24560182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pancreatic enzyme replacement therapy in cystic fibrosis: dose, variability and coefficient of fat absorption.
    Calvo-Lerma J; Martínez-Barona S; Masip E; Fornés V; Ribes-Koninckx C
    Rev Esp Enferm Dig; 2017 Oct; 109(10):684-689. PubMed ID: 28747058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evolution of pancreatic function during the first year in infants with cystic fibrosis.
    O'Sullivan BP; Baker D; Leung KG; Reed G; Baker SS; Borowitz D
    J Pediatr; 2013 Apr; 162(4):808-812.e1. PubMed ID: 23245194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of the treatment of pancreatic exocrine insufficiency on survival of patients with unresectable pancreatic cancer: a retrospective analysis.
    Domínguez-Muñoz JE; Nieto-Garcia L; López-Díaz J; Lariño-Noia J; Abdulkader I; Iglesias-Garcia J
    BMC Cancer; 2018 May; 18(1):534. PubMed ID: 29728096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of fibrosing colonopathy with pancreatic enzyme replacement therapy in patients with cystic fibrosis.
    Chiuve SE; Fife D; Leitz G; Peterson C; Campbell NM; Rennig A; Rodrigues L; Decktor D; Dowd C; Marshall BC; Borowitz D
    J Cyst Fibros; 2023 Nov; 22(6):1017-1023. PubMed ID: 37880023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exocrine pancreatic insufficiency following esophagectomy.
    Huddy JR; Macharg FM; Lawn AM; Preston SR
    Dis Esophagus; 2013 Aug; 26(6):594-7. PubMed ID: 23199208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hospitalization rates among patients with cystic fibrosis using pancreatic enzyme replacement therapy.
    Trapnell BC; Chen S; Khurmi R; Bodhani A; Kapoor M; Haupt M
    Chron Respir Dis; 2020; 17():1479973119900612. PubMed ID: 31984768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and efficacy of Creon® micro in children with exocrine pancreatic insufficiency due to cystic fibrosis.
    Kashirskaya NY; Kapranov NI; Sander-Struckmeier S; Kovalev V
    J Cyst Fibros; 2015 Mar; 14(2):275-81. PubMed ID: 25066363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Community Perspective on Pancreatic Enzyme Replacement Therapy in Cystic Fibrosis.
    Borowitz D; Brooks JF; Aliaj E; Gallotto D
    J Pediatr Gastroenterol Nutr; 2022 Nov; 75(5):e94-e97. PubMed ID: 36070542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between faecal pH and fat absorption in children with cystic fibrosis on a controlled diet and enzyme supplements dose.
    Calvo-Lerma J; Roca M; Boon M; Colombo C; de Koning B; Fornés-Ferrer V; Masip E; Garriga M; Bulfamante A; Asensio-Grau A; Andrés A; de Boeck K; Hulst J; Ribes-Koninckx C
    Pediatr Res; 2021 Jan; 89(1):205-210. PubMed ID: 32247283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pancreatic insufficiency, growth, and nutrition in infants identified by newborn screening as having cystic fibrosis.
    Bronstein MN; Sokol RJ; Abman SH; Chatfield BA; Hammond KB; Hambidge KM; Stall CD; Accurso FJ
    J Pediatr; 1992 Apr; 120(4 Pt 1):533-40. PubMed ID: 1552390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A high prevalence of chronic gastrointestinal symptoms in adults with cystic fibrosis is detected using tools already validated in other GI disorders.
    Hayee B; Watson KL; Campbell S; Simpson A; Farrell E; Hutchings P; Macedo P; Perrin F; Whelan K; Elston C
    United European Gastroenterol J; 2019 Aug; 7(7):881-888. PubMed ID: 31428412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of two pancreatic enzyme products for exocrine insufficiency in patients with cystic fibrosis.
    Taylor CJ; Thieroff-Ekerdt R; Shiff S; Magnus L; Fleming R; Gommoll C
    J Cyst Fibros; 2016 Sep; 15(5):675-80. PubMed ID: 27013382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.